These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 21821305)

  • 1. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.
    Pötter R; Georg P; Dimopoulos JC; Grimm M; Berger D; Nesvacil N; Georg D; Schmid MP; Reinthaller A; Sturdza A; Kirisits C
    Radiother Oncol; 2011 Jul; 100(1):116-23. PubMed ID: 21821305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.
    Mazeron R; Castelnau-Marchand P; Dumas I; del Campo ER; Kom LK; Martinetti F; Farha G; Tailleur A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
    Radiother Oncol; 2015 Feb; 114(2):257-63. PubMed ID: 25497872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
    Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.
    Sturdza A; Pötter R; Fokdal LU; Haie-Meder C; Tan LT; Mazeron R; Petric P; Šegedin B; Jurgenliemk-Schulz IM; Nomden C; Gillham C; McArdle O; Van Limbergen E; Janssen H; Hoskin P; Lowe G; Tharavichitkul E; Villafranca E; Mahantshetty U; Georg P; Kirchheiner K; Kirisits C; Tanderup K; Lindegaard JC
    Radiother Oncol; 2016 Sep; 120(3):428-433. PubMed ID: 27134181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
    Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
    Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A volumetric analysis of GTV
    Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
    Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
    Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F
    Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
    Pötter R; Tanderup K; Schmid MP; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Ristl R; Petric P; Nesvacil N; Kirchheiner K; Kirisits C; Lindegaard JC;
    Lancet Oncol; 2021 Apr; 22(4):538-547. PubMed ID: 33794207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsed low dose rate brachytherapy for uterine cervix carcinoma.
    Rogers CL; Freel JH; Speiser BL
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):95-100. PubMed ID: 9989519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of image guided brachytherapy for stage IB cervical cancer in the RetroEMBRACE study.
    Petric P; Lindegaard JC; Sturdza A; Fokdal L; Kirchheiner K; Tan LT; Schmid MP; Haie-Meder C; Jürgenliemk-Schulz IM; van Limbergen E; Hoskin P; Gillham C; Tharavichitkul E; Mahantshetty U; Villafranca E; Tanderup K; Kirisits C; Pötter R
    Radiother Oncol; 2021 Apr; 157():24-31. PubMed ID: 33476724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer.
    Tiwari R; Narayanan GS; Narayanan S; Suresh Kumar P
    Brachytherapy; 2020; 19(1):73-80. PubMed ID: 31813739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate-term results of image-guided brachytherapy and high-technology external beam radiotherapy in cervical cancer: Chiang Mai University experience.
    Tharavichitkul E; Chakrabandhu S; Wanwilairat S; Tippanya D; Nobnop W; Pukanhaphan N; Galalae RM; Chitapanarux I
    Gynecol Oncol; 2013 Jul; 130(1):81-5. PubMed ID: 23603369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late side effects of 3T MRI-guided 3D high-dose rate brachytherapy of cervical cancer : Institutional experiences.
    Vojtíšek R; Sukovská E; Baxa J; Budíková M; Kovářová P; Fínek J
    Strahlenther Onkol; 2019 Nov; 195(11):972-981. PubMed ID: 31309266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience.
    Nomden CN; de Leeuw AA; Roesink JM; Tersteeg RJ; Moerland MA; Witteveen PO; Schreuder HW; van Dorst EB; Jürgenliemk-Schulz IM
    Radiother Oncol; 2013 Apr; 107(1):69-74. PubMed ID: 23639580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
    Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
    Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.